You have read all your free articles, to continue reading subscribe to read the rest of this content.
Only 34 countries have national plans to fight antibiotic resistance, which means very few are prepared to tackle an outbreak of a "superbug" infection, according to the World Health Organization (WHO). The 34 nations that indicated they were addressing the problem represent a quarter of the 133 Already a subscriber…
Gilead Sciences, Inc., has acquired EpiTherapeutics ApS for $65 million, subject to certain purchase price adjustments, to be financed through available cash on hand, according to FierceBiotech. EpiTherapeutics has a library of small molecule inhibitors of epigenetic regulation of gene transcAlready a subscriber Login You have read all your free articles, to…
Attorney Stefan Wendén, a managing partner in a Swedish law firm, is now part of the Malmö-based research park Medeons first virtual management team. The new concept is being tested at Richter Life Science Development, founded by Agneta Richter Dahlfors, professor of microbiology at Karolinska InsAlready a subscriber Login You…
Swiss Roche has announced that the company has agreed to acquire Danish biopharmaceutical firm Santaris Pharma for USD 450 million. The plan is to expand discovery and development of RNA-targeting medicines. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that haAlready a subscriber Login You have read all…
